documents: FDA-2011-D-0611-0066

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2011-D-0611-0066 FDA FDA-2011-D-0611 New and Revised Draft Q&As on Biosimilar Development and the BPCI Act (Revision 2); Guidance for Industry; Draft Guidance Other Guidance 2018-12-11T05:00:00Z 2018 12 2018-12-11T05:00:00Z   2024-11-12T22:53:26Z   1 0 0900006483988a81

Links from other tables